Wang Z - Search Results

1

Immunoreactivity and prognostic value of tumor-associated glycoprotein 72 in primary gallbladder carcinoma.

Ouyang M, Wu W, Zou Y, Zhou J, Wang Z, Wan X. Ouyang M, et al. Among authors: wang z. Surg Oncol. 2010 Jun;19(2):82-7. doi: 10.1016/j.suronc.2009.03.010. Epub 2009 May 15. Surg Oncol. 2010. PMID: 19447030 Review.

2

Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.

Gao YW, Chen YX, Wang ZM, Zhou LD, Li XY, Li LX, Luo QZ, Tian W, Fu CY, Zhou JH. Gao YW, et al. Hepatogastroenterology. 2008 Mar-Apr;55(82-83):345-50. Hepatogastroenterology. 2008. PMID: 18613363

3

Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.

Tan H, Ye K, Wang Z, Tang H. Tan H, et al. Among authors: wang z. Jpn J Clin Oncol. 2008 Aug;38(8):528-33. doi: 10.1093/jjco/hyn065. Epub 2008 Jul 29. Jpn J Clin Oncol. 2008. PMID: 18664479

4

CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma.

Tan H, Ye K, Wang Z, Tang H. Tan H, et al. Among authors: wang z. Transl Res. 2008 Sep;152(3):143-9. doi: 10.1016/j.trsl.2008.07.005. Epub 2008 Aug 12. Transl Res. 2008. PMID: 18774544

5

The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma.

Zhou L, Huang Y, Li J, Wang Z. Zhou L, et al. Among authors: wang z. Med Oncol. 2010 Jun;27(2):255-61. doi: 10.1007/s12032-009-9201-4. Epub 2009 Mar 20. Med Oncol. 2010. PMID: 19301157

6

Prognostic significance of neuroepithelial transforming protein 1 in hepatocellular carcinoma.

Ye K, Wang Z, Zhang G, Liang S. Ye K, et al. Among authors: wang z. J Invest Surg. 2010 Jun;23(3):163-9. doi: 10.3109/08941939.2010.481010. J Invest Surg. 2010. PMID: 20590388 Free article.

7

Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.

Zhang G, Liu T, Wang Z. Zhang G, et al. Among authors: wang z. J Invest Surg. 2012 Apr;25(2):93-9. doi: 10.3109/08941939.2011.606875. Epub 2011 Sep 26. J Invest Surg. 2012. PMID: 21942217 Free article.

8

High-mobility group box 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.

Jiang W, Wang Z, Li X, Fan X, Duan Y. Jiang W, et al. Among authors: wang z. Pathol Oncol Res. 2012 Apr;18(2):293-8. doi: 10.1007/s12253-011-9442-3. Epub 2011 Sep 7. Pathol Oncol Res. 2012. PMID: 21953322 Free article.

9

Expression of high mobility group A2 is associated with poor survival in hepatocellular carcinoma.

Wu L, Wang Z, Lu R, Jiang W. Wu L, et al. Among authors: wang z. Pathol Oncol Res. 2012 Oct;18(4):983-7. doi: 10.1007/s12253-012-9514-z. Epub 2012 Mar 30. Pathol Oncol Res. 2012. PMID: 22461106 Free article. No abstract available.

10

Growth arrest-specific homeobox is associated with poor survival in patients with hepatocellular carcinoma.

Zhou P, Chen Z, Chang RM, Jiang W, Wu LL, Wang ZM. Zhou P, et al. Among authors: wang zm. Med Oncol. 2012 Dec;29(5):3063-9. doi: 10.1007/s12032-012-0258-0. Epub 2012 May 27. Med Oncol. 2012. PMID: 22644917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138,927 results

Search Page

Filters